Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
1989 • 932 citations
TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM
1989 • 252 citations
Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer
1988 • 247 citations
Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens.
1985 • 224 citations
Endometrial morphology in asymptomatic postmenopausal women
1991 • 147 citations
Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients
1981 • 138 citations
Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line).
1989 • 108 citations
Protection Against Endometrial Carcinoma by Combination-Product Oral Contraceptives
1982 • 103 citations
Endometrial Polyps in Postmenopausal Patients Receiving Tamoxifen
1989 • 99 citations
Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients
1990 • 94 citations
Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer—Preliminary report
1991 • 89 citations
Endocrine Effects of Tamoxifen in Postmenopausal Breast Cancer Patients
1984 • 53 citations
Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma
1990 • 48 citations
Endometrial carcinoma in five patients with breast cancer on tamoxifen therapy.
1990 • 39 citations
Epidemiology of Cancer of the Endometrium
1982 • 36 citations
Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women
1990 • 29 citations
Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy. Case report
1990 • 29 citations
Treatment of Hyperplasia and Carcinoma In Situ of the Endometrium
1982 • 11 citations
Deleted Work
1955 • 0 citations